Full-Time
Lead Product Owner
Real World Data
Posted on 9/11/2026
LabCorp
10,001+ employees
Global life sciences R&D services
Compensation Overview
$110k - $130k/yr
No H1B Sponsorship
Remote in USA + 1 more
More locations: Durham, NC, USA
Remote
Must work standard business hours in your local time zone.
Bachelor's, Master's
 Product (1) |
|---|
Get referred to LabCorp
See people who can refer or advise you
- A high school diploma or GED with at least 9 years of experience supporting data product development, product ownership, product management, or business analysis; or an associate degree with at least 7 years of such experience; or a bachelor's degree in Computer Science, Information Management, Mathematics, Statistics, or Life Sciences with at least 5 years of such experience.
- At least 2 years of experience using tools and methodologies supporting requirements management, backlog prioritization, or Agile workflows.
- At least 2 years of experience building products using Real World Data within the life sciences or healthcare industry.
- At least 2 years of experience using project lifecycle management tools such as Jira or Confluence.
- At least 2 years of experience with regulatory and compliance standards relevant to Real World Data and Real World Evidence.
- Knowledge of Real World Data, Real World Evidence, and the healthcare or life sciences industry.
- Knowledge of HIPAA, data privacy laws, AI governance principles, and related industry standards.
- Ability to communicate technical concepts effectively to technical and non-technical audiences.
- Skills in stakeholder engagement, facilitation, negotiation, and consensus building.
- Strong analytical, problem-solving, and decision-making skills.
- Ability to evaluate information, identify risks, and develop practical recommendations.
- Ability to build and maintain effective working relationships across cross-functional teams.
- Ability to influence outcomes and drive alignment among diverse stakeholders.
- Strong organizational skills and attention to detail.
- Ability to manage multiple priorities in a fast-paced environment.
- Ability to work independently in a remote environment.
- Partner with Real World Data leadership and senior stakeholders to refine and execute the product roadmap.
- Translate product strategy into detailed product vision, requirements, specifications, and execution plans.
- Collaborate with business leaders, business development, marketing, and other stakeholders to define use cases and develop products for new customer segments.
- Identify and evaluate product requirements, dependencies, risks, and implementation considerations.
- Contribute to business case development and return-on-investment analyses.
- Prepare and deliver presentations that communicate strategic initiatives, business value, and technical concepts to diverse audiences.
- Monitor emerging technologies, market trends, and innovations relevant to Real World Data products and customer needs.
- Lead coordination of product development activities throughout the product lifecycle.
- Own and prioritize the product backlog to ensure alignment across cross-functional teams.
- Identify resource requirements and partner with stakeholders to support product development needs.
- Coordinate with project and delivery teams to support release planning and delivery timelines.
- Collaborate with technical teams, business partners, and subject matter experts to clarify requirements and delivery expectations.
- Facilitate discussions that support decision-making, requirement validation, and workflow optimization.
- Communicate product progress, risks, issues, and mitigation plans to stakeholders and leadership.
- Serve as the primary point of contact for product requirements, feature definition, and product-related inquiries.
- Oversee development and maintenance of product documentation, requirements, and supporting materials.
- Verify that products and features meet established requirements and acceptance criteria.
- Support adoption of Agile methodologies and continuous improvement activities.
- Collaborate with technical, business development, and commercial operations teams to support successful product delivery.
- Drive process improvement initiatives that enhance operational effectiveness and stakeholder engagement.
- A master's degree in Computer Science, Information Management, Mathematics, Statistics, or Life Sciences with at least 3 years of experience supporting data product development, product ownership, product management, or business analysis.
- At least 2 years of experience contributing to business case development, product strategy, or product roadmap planning.
- At least 2 years of experience working with healthcare, life sciences, clinical, laboratory, claims, or other real-world healthcare datasets.
- At least 2 years of experience supporting Agile product development teams in a cross-functional environment.
- At least 2 years of experience leveraging artificial intelligence-enabled tools to support product development, requirements management, or operational efficiency.
- Excellent verbal, written, presentation, and interpersonal communication skills.
- Demonstrated professionalism, adaptability, persistence, and a continuous learning mindset.
Labcorp provides end-to-end R&D services for life sciences and agricultural clients, including crop protection, with testing and regulatory support. It runs physicochemical analyses, safety assessments, and inhalation toxicology studies using specialized labs to evaluate inhaled substances. It differentiates itself with a global footprint and an integrated set of services across the product lifecycle, including regulatory submissions. Its goal is to help clients bring safe, effective products to market efficiently by applying rigorous science and scalable testing.
Company Size
10,001+
Company Stage
IPO
Headquarters
Burlington, Vermont
Founded
1976
Get referred to LabCorp
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue rose 5.8% to $3.73 billion; EPS jumped 28.5%.
- Labcorp raised 2026 guidance on July 30 and authorized another $1.0 billion buyback.
- August 2026 launches added ColoSense nationwide, Marker, and hepatitis D testing.
What critics are saying
- Sept. 4, 2026 settlement restricts labcorp.com tracking for two years, hitting digital acquisition.
- The $35 million AMCA breach settlement keeps privacy liabilities alive through 2026 hearings.
- Repeated website surveillance scandals invite state AG scrutiny and cripple consumer diagnostics growth.
What makes LabCorp unique
- Sept. 8, 2026 MLM acquisition gives Labcorp four-continent wholly owned central-lab coverage.
- Labcorp supported over 85% of FDA-approved 2025 new drugs and therapeutics.
- Global Trial Connect unifies samples, biomarker data, and investigator workflows across studies.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
Unlimited Paid Time Off
Tuition Reimbursement
Employee Stock Purchase Plan
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 0%Labcorp has acquired MLM Medical Labs, a global central and specialty laboratory provider with operations in the United States, Germany and South Africa. Financial terms were not disclosed. The acquisition establishes Labcorp as the only central laboratory provider with a wholly owned laboratory network across four continents: North America, Europe, Asia and Africa. MLM operates Africa's first fully CAP-accredited central laboratory. The deal expands Labcorp's presence in key clinical research regions and strengthens its biomarker and specialty testing capabilities. It enhances the company's ability to support multinational clinical trials with consistent scientific, operational and regulatory oversight. Labcorp employs nearly 71,000 people serving clients in approximately 100 countries.
If you conducted Search Queries on Labcorp's website from May 1, 2021 to April 1, 2026, a class action settlement may affect you. Sep 04, 2026, 20:00 ET GREENSBORO, N.C., Sept. 4, 2026 /PRNewswire/ - WHAT IS THIS ABOUT? Plaintiffs allege that Labcorp violated California and Pennsylvania wiretapping laws by facilitating, through third-party tracking technologies, the interception of personally identifiable information and searches that users conducted on Labcorp's website. Labcorp denies these and all other allegations of wrongdoing and liability, and denies all claims asserted against it. Plaintiffs and Labcorp have agreed to a settlement to resolve this lawsuit. The Court has not decided who is right or wrong. WHO IS INCLUDED? The Settlement Classes are defined as follows: * California Settlement Class: All persons in California who conducted Search Queries on Labcorp's website from May 1, 2021 to April 1, 2026. * Pennsylvania Settlement Class: All persons in Pennsylvania who conducted Search Queries on Labcorp's website from May 1, 2021 to April 1, 2026. "Search Queries" means search terms and/or search queries, including but not limited to, entry of any search term(s) into a search bar or search menu on the Labcorp website, www.labcorp.com and its subpages, as well as making any selection(s) from any drop-down menu on the website. WHAT DOES THE SETTLEMENT PROVIDE? If the settlement is approved, or after any potential appeals of that approval are resolved, Labcorp has agreed to the following terms: * Not using or enabling certain tracking technologies (as defined by the settlement agreement, but examples include the Meta Pixel and Google Analytics) on its website, labcorp.com or any of its subpages, for two years; * Conducting an annual review and preparing a compliance report demonstrating that it is not using technologies prohibited by the settlement; * Creating or maintaining a written policy regarding the appropriate use of externally developed tracking technologies on its website; and * Designating a senior employee responsible for overseeing compliance with the above terms. YOUR OPTIONS. The settlement provides only injunctive relief (e.g., business practice terms). Under the settlement terms, Settlement Class Members (except for Settlement Class Representatives) will not release any claims for damages or other monetary relief. If the settlement is approved, you will give up the right to sue Labcorp and other affiliated entities for injunctive relief claims arising from or related to the allegations in this lawsuit. Because the plaintiffs are seeking only injunctive relief and because Labcorp is only agreeing to injunctive relief, Settlement Class Members cannot opt out of the settlement. This means that all members of the Settlement Class will be bound by the settlement, if the Court approves it. If you are a Settlement Class Member, you may object to or comment upon the proposed settlement, explaining why you believe the settlement should not be approved. All objections must be postmarked by November 23, 2026. For more information on how to object, visit www.LaboratoryCorporationWebsiteSettlement.com or call 1-877-378-7520. At the Final Approval Hearing, the Court will consider whether the settlement is fair, reasonable, and adequate, and whether to award attorneys' fees, expenses, and service awards, and in what amounts. If there are objections, the Court will consider them. After the hearing, the Court will decide whether to approve the Settlement. It is not necessary for you to attend this hearing, but you may attend at your own expense. If you have any questions or want more information about the settlement, please visit www.LaboratoryCorporationWebsiteSettlement.com or contact the Settlement Administrator at 1-877-378-7520. SOURCE U.S. District Court for the Middle District of North Carolina
Ultrahuman, maker of smart health devices including the M1 Live glucose monitoring wearable and Ring Air smart ring, has raised approximately $60 million in its latest funding round. Investors include Qualcomm Ventures, Alpha Wave, LabCorp, Deepinder Goyal, and Blume Ventures. The funding values the startup at $363 million, representing a 65% increase from its previous valuation. Co-founders Mohit Kumar and Vatsal Singhal plan to use the capital for growth, expansion, and general corporate purposes. The round follows Ultrahuman's previous $35 million raise.
Human Risk Management Leaders from Reveal Risk, Bayer, and Labcorp to speak at HRMCon 2026. Enterprise CISOs and cybersecurity leaders will share real-world lessons for strengthening Workforce Security, advancing Security Behavior Management, and reducing risk across humans and AI agents AUSTIN, Texas, August 31, 2026 (Newswire.com) - Living Security, the global leader in Human Risk Management (HRM), today announced the full speaker roster for HRMCon 2026, its annual Human Risk Management conference taking place September 10 in Austin, Texas, with a live virtual broadcast available worldwide. The lineup brings together enterprise practitioners, analysts, cybersecurity strategists, and workforce security leaders from Forrester, Bayer, Labcorp, Reveal Risk, Cybersecurity Insights, and Living Security. Through real-world case studies and strategic discussions, speakers will examine how organizations are building, funding, and operationalizing Human Risk Management programs to reduce cyber risk across employees, privileged users, contractors, and AI agents. "Security leaders need more than theories about Human Risk Management-they need to understand what it takes to build these programs in the real world," said Ashley Rose, CEO and Co-Founder of Living Security. "This year's speakers will share the decisions, obstacles, data challenges, and business cases behind their programs, giving attendees actionable ideas they can apply within their own organizations." Enterprise Human Risk Management Leaders Share What Works Featured speakers include: * Jinan Budge, Vice President and Research Director at Forrester, providing an independent market outlook on Human Risk Management, changing buyer priorities, and the impact of AI-enabled attacks. * Damon DePaolo of CVS Health, sharing insights from building Human Risk Management programs, including how to align stakeholders, validate assumptions with a live-data proof of concept, and establish success criteria that earn organizational support. * Jennifer Miller of Bayer, explaining how Bayer expanded workforce risk visibility across more than half of its workforce in six months without waiting for a perfect data environment. * Ashley Atiles and Alfonso Mancuso of Labcorp, discussing how behavioral intelligence strengthened phishing-resistant multifactor authentication by revealing user friction, workarounds, resistance, and trust gaps. * Aaron Pritz and Jim Wailes of Reveal Risk, showing how security teams can reduce risk by redesigning high-risk business workflows and making secure behavior easier. * Matthew Rosenquist of Cybersecurity Insights, examining the future of autonomous prevention, adaptive controls, and human accountability as AI agents become part of the workforce. * Gary S. Chan, Security Mentalist and CISO, delivering an interactive closing keynote on the psychology of deception, influence, trust, and security decision-making. The conference will also feature Living Security CEO Ashley Rose and Living Security leaders Kelly Harward and Mike Siegel, who will examine how Human Risk Management must evolve as workforce identities, access patterns, and attack pathways expand beyond employees and email. Workforce Security Lessons from Complex Enterprises Speakers will address some of the most persistent challenges facing enterprise cybersecurity and Workforce Security leaders, including: * Building an enterprise business case for Human Risk Management * Aligning security, identity, compliance, and business stakeholders * Advancing from security awareness training to Security Behavior Management * Applying behavioral intelligence to identity and access controls * Connecting workforce risk signals to real-time security actions * Launching an HRM program with a few critical data sources and expanding over time * Measuring reductions in cyber incidents rather than activities alone * Governing access and accountability across humans and AI agents The sessions will give CISOs, security practitioners, identity leaders, GRC professionals, and Human Risk Management teams actionable guidance for implementing and scaling HRM in complex enterprise environments. Human Risk Management for Humans and AI Agents As AI agents and autonomous systems gain access to enterprise data, applications, and workflows, Workforce Security is expanding beyond employee behavior. Security teams must increasingly assess risk across human and non-human identities while establishing clear governance, access controls, accountability, and measurable security outcomes. HRMCon 2026 will examine how organizations can combine behavioral, identity, and threat intelligence to identify elevated workforce risk, prioritize interventions, and strengthen security controls before incidents occur. HRMCon 2026 will be held September 10, 2026, at The University of Texas Club in Austin, Texas, with a live virtual broadcast available to attendees worldwide. View the full HRMCon 2026 agenda and register to attend in person or virtually at: HRMCon 2026 Human Risk Management Conference About Living Security Living Security is the global leader in Human Risk Management (HRM), helping organizations identify, measure, and reduce workforce cyber risk across humans and AI agents. Its AI-native Human Risk Management platform combines behavioral, identity, and threat intelligence to predict risk, guide response, and prevent cyber incidents before they occur. By connecting security data to measurable business outcomes, Living Security enables organizations to continuously reduce workforce risk while strengthening organizational resilience. Media Contact
Labcorp launches next generation of Labcorp Global Trial Connect to help sponsors and investigator sites navigate clinical trial complexity. PRNewswire 31-Aug-2026 7:00 AM Enhanced digital experience designed to improve visibility, simplify workflows and support faster decision-making BURLINGTON, N.C., Aug. 31, 2026 /PRNewswire/ - Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory solutions, today announced enhancements to the digital experience of Labcorp Global Trial Connect(TM), the company's portfolio of clinical trial services, data and technology that enhances and accelerates delivery. The newly redesigned platform introduces new capabilities across the Labcorp Sponsor(TM) and Labcorp Investigator(TM) portal experiences of Global Trial Connect, providing greater visibility across studies, simplifying workflows and helping sponsors and investigator sites make faster, more informed decisions. "As clinical trials become increasingly complex, sponsors and investigator sites need technology that helps them work more effectively," said Brian Caveney, M.D., EVP and president, Biopharma Laboratory Services and chief medical and scientific officer, Labcorp. "The latest enhancements to Global Trial Connect make it easier to access insights, manage study activities and navigate trial complexity with confidence, allowing customers to focus less on operational tasks and more on advancing research and supporting patients."